Engineered Cells for Selective Detection and Remediation of Hg2+Based on Transcription Factor MerR R

来源 :第十一届全国化学生物学学术会议 | 被引量 : 0次 | 上传用户:newio
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Mercury pollution has been one of the most serious environmental problems today.The detection and remediation of mercury contamination are of special concern due to its nondegradable nature,bioaccumulation effect,and significant toxicity[1,2].In this research,the whole-cell based detection and remediation systems for Hg2+were engineered based on the cell surface engineering technique and transcriptional activation mechanism of metalloprotein MerR.The engineered biodetection system showed high selectivity for Hg2+over other metal ions with the detection limit as low as 0.1 nM.It also permitted a rapid,visual,and on-site detection of bioavailable Hg2+for large-scale water samples with simple processes.The engineered bioremediation system,which was more efficient than the most current biosystems with limited adsorption capacities,could continuously reduce mercury contamination in wide concentration by transforming highly toxic Hg2+to volatile and much less deleterious Hg0 with extraordinary selectivity.In addition,the bioremediation system could perform function in the absence of extra inductive agent and showed an increased protection of cells against Hg2+biotoxicity.By fully imitating and utilizing the microorganisms,the engineered biochemical systems have great potential in the practical application of detecting and remediating Hg2+in the contaminated aquatic systems[3].
其他文献
替莫唑胺(TMZ)是治疗恶性多形性胶质母细胞瘤(GBM)的一线药物,通过胞内弱碱性环境中降解为高活性中间体MTIC而对DNA的甲基化作用并产生细胞毒性.[1]然而,TMZ和MTIC 在体内的化学或生物受体迄今尚未发现,影响了人们对TMZ 和MTIC 药物作用的理解.我们研究了金属离子与TMZ 和MTIC 在水溶液中的作用,研究发现铜离子是十分有潜力的MTIC 受体,它能够在近中性环境中稳定结合MT
癌症在世界范围内正处于高发态势。尽管铂类药物在临床上表现出显著疗效,但随着人们对系统生物学和药理学认识的逐渐深入,发现它们也存在严重毒副作用和易产生耐药性等问题。人们逐渐认识到非铂类金属药物在治疗癌症时可能起到的重要作用。我们设计开发了含有N^N-,C^N-,C^C-,P^P-,P^O-,C^O-螯合配体的系列半三明治结构金属有机铱、钌抗癌配合物,这些化合物体外抗癌活性高出顺铂数十倍,具有不同于临
A tumor-related stimuli-activatable and biodegradable nanoplatform for effective photodynamic therapy(PDT)towards precision medicine is highly desirable but is still a pressing unmet need1.Here,we dev
Biocompatible chemical protein cleavage methods have been long-sought to replace enzymatic cleavages,but have yet to be realized.Here,we report the development of the SNAC-tag(Sequence-specific Nickel
A series of Ruthenium(Ⅱ)polypyridiyl complexes containing terminal alkyl groups have synthesized and characterized,which are able to reacted with the metabolic precursor via copper(Ⅰ)-catalyzed alkyne
会议
Half-sandwich and cyclometalated metal-based anticancer agents have great distinction in their mechanisms of actions(MoAs)[1-2].To further understand the MoAs,two Ir(Ⅲ)complexes with the modified α-li
醇的选择性氧化是有机合成化学中一种重要的官能团转化反应,其对应的催化产物醛或酮是合成药物、维生素及香料等的重要前体,在基础研究领域和精细化工生产中占有重要的地位。传统上这一转化大多采用化学计量的氧化剂,比如铬试剂、锰试剂及其它过渡金属氧化物、高价碘试剂等,[1]这些生产工艺存在原子经济性差、环境污染严重和成本较高等问题,已无法满足现代社会发展的需要。因此,如何通过一些简单、易行的方法将醇高效地选择
Addressable and programmable DNA nanostructures are promising biomaterials to arrange multiple functional components for efficient and site-specific drug delivery.[1] Herein,we report a double bundle
4,7-二苯基-1,10-菲啰啉(DIP)作为一种重要的N^N 二齿结构的多吡啶配体在含金属药物的分子结构设计发挥着重要作用。放射增敏剂是一类能显著提高肿瘤放射敏感性的药物,在恶性肿瘤的放射治疗中发挥着重要作用。相对于有机小分子放射增敏剂,金属配合物由于其中的金属元素具有较强的光电吸收截面,能显著提高机体组织对高能射线的吸收强度。因此,理论上金属配合物是一类理想的放射增敏剂。基于此,我们设计合成了